Hovan Ramps Up Market Neutral Fund Team

Feb 6 2008 | 8:44am ET

Hovan Capital Management, a San Francisco-based healthcare focused long/short fund, has hired Ajim Tamboli as a senior portfolio manager of the HCM Market Neutral Fund. Tamboli previously served as a senior small biotechnology analyst at Lehman Brothers in San Francisco.

In addition, Lisa Lee-Hwong, previously with SAC Capital Advisors, has joined the firm to support Tamboli as a portfolio manager focused on emerging science. Current HCM analyst Mikael van Loon will be promoted to the role of portfolio manager in charge of top-down quantitative portfolio risk management.

“Ajim’s experience and interaction with the management teams of portfolio companies coupled with Dr. Lee-Hwong’s scientific research experience will provide a strong positive environment in HCM’s public equity healthcare research department,” said Kurt Hovan, president and CIO of HCM.

“Mikael has mastered HCM’s short portfolio quantitative process and is ready to assume the role of portfolio manager in the fund.”

Hovan Capital Management was established in September 1998.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Trump Attends 'Villains and Heroes' Costume Party Dressed As...Himself

Dec 5 2016 | 11:16pm ET

U.S. President-elect Donald Trump attended a "Villains and Heroes" costume party...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR